Bilal Arif

Companies

• KalVista Pharmaceuticals, Inc.Chief Operations Officer Oct 8, 2025 to now¹
• Sarepta TherapeuticsChief Tech Ops Officer Jan 4, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Sarepta Therapeutics SRPT32,500 shares³$575.7K at $17.71Mar 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 10, 2025Granted 8,276 shares of Sarepta Therapeutics³
• Mar 10, 2025Shares withheld for tax 523 shares at $100.13 of Sarepta Therapeutics³
• Mar 7, 2025Shares withheld for tax 8,527 shares at $103.70 of Sarepta Therapeutics⁴
• Mar 7, 2025Shares withheld for tax 508 shares at $103.70 of Sarepta Therapeutics⁴
• Mar 6, 2025Exercised options 17,500 shares of Sarepta Therapeutics⁴
• Mar 4, 2025Shares withheld for tax 233 shares at $101.34 of Sarepta Therapeutics⁵
• Mar 4, 2025Shares withheld for tax 281 shares at $101.34 of Sarepta Therapeutics⁵
• Mar 3, 2025Shares withheld for tax 719 shares at $103.77 of Sarepta Therapeutics⁶
• Jun 25, 2024Sold 3,898 shares at $163.23 of Sarepta Therapeutics⁷
• Jun 24, 2024Sold 224 shares at $167.13 of Sarepta Therapeutics⁷
• Jun 24, 2024Sold 700 shares at $166.10 of Sarepta Therapeutics⁷
• Jun 24, 2024Sold 300 shares at $164.61 of Sarepta Therapeutics⁷
• Jun 24, 2024Sold 1,055 shares at $163.83 of Sarepta Therapeutics⁷
• Jun 24, 2024Sold 5,580 shares at $162.31 of Sarepta Therapeutics⁷
• Jun 24, 2024Shares withheld for tax 2,352 shares at $164.64 of Sarepta Therapeutics⁷
• Jun 21, 2024Exercised options 6,250 shares of Sarepta Therapeutics⁷
• Mar 8, 2024Shares withheld for tax 472 shares at $123.14 of Sarepta Therapeutics⁸
• Mar 7, 2024Shares withheld for tax 506 shares at $120.49 of Sarepta Therapeutics⁸
• Mar 4, 2024Shares withheld for tax 237 shares at $125.32 of Sarepta Therapeutics⁹
• Mar 4, 2024Shares withheld for tax 285 shares at $125.32 of Sarepta Therapeutics⁹
• Mar 1, 2024Shares withheld for tax 114 shares at $126.19 of Sarepta Therapeutics¹⁰
• Mar 1, 2024Sold 457 shares at $129.71 of Sarepta Therapeutics¹⁰
• Mar 1, 2024Sold 1,543 shares at $128.58 of Sarepta Therapeutics¹⁰
• Mar 1, 2024Granted 6,000 shares of Sarepta Therapeutics¹⁰
• Mar 1, 2024Shares withheld for tax 251 shares at $126.19 of Sarepta Therapeutics¹⁰